Huiren Zhuang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Combination Therapy

Induced Apoptosis

Immune Response

Infectious Diseases

Top Venues

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Huiren Zhuang, Zhenghuan Yang, Tianhao Chen, Nan Jing, Yalin Zhou, Guoqiang Jiang, Yi Wang, Zhao Wang, Zheng Liu
Boosting HSA Vaccination with Jujube Powder Modulating Gut Microbiota Favorable for Arginine Metabolism. Nutrients 15 (8) (2023)
Huiren Zhuang, Zhenghuan Yang, Tianhao Chen, Nan Jing, Yalin Zhou, Guoqiang Jiang, Yi Wang, Zhao Wang, Zheng Liu
Boosting HSA Vaccination with Jujube Powder Modulating Gut Microbiota Favorable for Arginine Metabolism. Nutrients 15 (8) (2023)
Huiren Zhuang, Zhenghuan Yang, Tianhao Chen, Nan Jing, Yalin Zhou, Guoqiang Jiang, Yi Wang, Zhao Wang, Zheng Liu
Boosting HSA Vaccination with Jujube Powder Modulating Gut Microbiota Favorable for Arginine Metabolism. Nutrients 15 (8) (2023)
Huiren Zhuang, Zhenghuan Yang, Tianhao Chen, Nan Jing, Yalin Zhou, Guoqiang Jiang, Yi Wang, Zhao Wang, Zheng Liu
Boosting HSA Vaccination with Jujube Powder Modulating Gut Microbiota Favorable for Arginine Metabolism. Nutrients 15 (8) (2023)
Nan Jing, Luoyang Wang, Huiren Zhuang, Chao Ai, Guoqiang Jiang, Zheng Liu
Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer. Journal of immunology research 2022 (2022)
Huiren Zhuang, Nan Jing, Luoyang Wang, Guoqiang Jiang, Zheng Liu
Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8+ T Cells While Inhibiting Eosinophilia. Nutrients 13 (8) (2021)
Nan Jing, Luoyang Wang, Huiren Zhuang, Guoqiang Jiang, Zheng Liu
Ultrafine Jujube Powder Enhances the Infiltration of Immune Cells during Anti-PD-L1 Treatment against Murine Colon Adenocarcinoma. Cancers 13 (16) (2021)
Luoyang Wang, Guoqiang Jiang, Nan Jing, Xuerun Liu, Huiren Zhuang, Wenfeng Zeng, Wei Liang, Zheng Liu
Downregulating testosterone levels enhance immunotherapy efficiency. Oncoimmunology 10 (1) (2021)